Replies to post #24773 on Kali Inc. (KALY)

[BDIY]

“We investigated the effects of a novel, new agent for the oral treatment of lung diseases like inflammation of the lung airways in nonhuman primates with chronic pulmonary fibrosis. The new NCM Biotech supplement was evaluated at 3 separate concentrations and compared to placebo treated animals. After only 2 weeks of daily oral treatment, a 5 fold dilution of the supplement extract increased respiration rate by 55%, airway flow rate by 82%, inspiratory airway flow velocity by 149%, and tidal volume by 38% compared to each animal’s own control values.... "

I LIKE THIS !! :-)
$KALY

[kc381]

Oops we may have a problem. I was looking forward to this information however since COPD and Pulmonary Fibrosis are not at all the same and they are referring to them as if they are that raises a red flag. PF a restrictive lung disease and COPD is obstructive, this news is medically questionable.
Bummed.

[JMC21]

This extraction process is "THE REAL DEAL". All of the research is pointing this out!!!!!!! This will garner a lot of attention. Just a matter of time and BOOM!!!!!!!